Home
Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical Market Share Analysis for May 2026

제약회사, 광동제약, 비타500, 옥수수수염차, 헛개차, 경옥고, 공진단 등 제품 소개, 건강 정보 제공

Food and Drink > Food and Drink - Other

Domainekdp.com

Year Founded--

Employees1001 - 5000

Annual Revenue> $1B

Kwang Dong Pharmaceutical

Kwang Dong Pharmaceutical (including company regionals)

ekdp.com

See more website traffic and engagement information

Kwang Dong Pharmaceutical Revenue up to May 2026 is > 1B

revenue generated by Kwang Dong Pharmaceutical top domains

Kwang Dong Pharmaceutical top domains revenue over 3 years

Revenue for Kwang Dong Pharmaceutical top domains

ekdp.com> 1B

See more with Sales Intelligence

Total visits to Kwang Dong Pharmaceutical's top domains

Understand Kwang Dong Pharmaceutical market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ekdp.com226.6K

See more with Sales Intelligence

Avg. visit duration in Kwang Dong Pharmaceutical's top domains

Analyze Kwang Dong Pharmaceutical engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ekdp.com00:09:09

See more with Sales Intelligence

Avg. pageviews on Kwang Dong Pharmaceutical's top domains

See how Kwang Dong Pharmaceutical keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ekdp.com4.15

See more with Sales Intelligence

Kwang Dong Pharmaceutical top competitors by domain

Top similar sites in May 2026, ranked by their affinity

yuhan.co.krCompany NameYuhanEmployees1001 - 5000HQKorea, Republic of, Dongjak-guAnnual revenue> $1BTotal visits197KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Kwang Dong Pharmaceutical

These are the website technologies, by industry, used by Kwang Dong Pharmaceutical top domains

Social (9)

Google+ Platform

Advertising (4)

DoubleClick

Audio Video Media (2)

YouTube

Conversion & Analytics (2)

Google Analytics

More Technologies

8

See all

News & Signals from Kwang Dong Pharmaceutical

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEkdp partners with Oxford Cancer Biomarkers Ltd.Kwang Dong Pharmaceutical, a human healthcare provider in South Korea, has forged a strategic partnership with Oxford Cancer Biomarkers (OCB), a spinout from Oxford University that is developing tests to allow medicines to be personalized for cancer patients.

NewsEkdp is developing Vyleesi in the.We also entered into a license agreement with Kwangdong Pharma for exclusive rights to develop and commercialize Vyleesi in the Republic of Korea.

NewsAntibe Therapeutics Inc. partnered with Ekdp on Sep 5th '18.Antibe Therapeutics has entered into an exclusive licensing agreement with Kwang Dong Pharmaceutical Co., Ltd. for the development and commercialization of Antibe’s lead drug, ATB-346, in South Korea (the “Region”).